Tonix Pharmaceuticals Holding Stock Market Value
| TNXP Stock | USD 0.19 0.00 0.00% |
| Symbol | Tonix |
Tonix Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tonix Pharmaceuticals. If investors know Tonix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tonix Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (80.39) | Revenue Per Share 6.352 | Return On Assets (0.52) | Return On Equity (1.63) |
The market value of Tonix Pharmaceuticals is measured differently than its book value, which is the value of Tonix that is recorded on the company's balance sheet. Investors also form their own opinion of Tonix Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Tonix Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tonix Pharmaceuticals' market value can be influenced by many factors that don't directly affect Tonix Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tonix Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tonix Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tonix Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Tonix Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tonix Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tonix Pharmaceuticals.
| 11/03/2024 |
| 12/03/2024 |
If you would invest 0.00 in Tonix Pharmaceuticals on November 3, 2024 and sell it all today you would earn a total of 0.00 from holding Tonix Pharmaceuticals Holding or generate 0.0% return on investment in Tonix Pharmaceuticals over 30 days. Tonix Pharmaceuticals is related to or competes with Sonnet Biotherapeutics, Palisade Bio, Ibio, Jaguar Animal, Vaxart, Bright Minds, and Virax Biolabs. Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, deve... More
Tonix Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tonix Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tonix Pharmaceuticals Holding upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 34.76 | |||
| Value At Risk | (11.76) | |||
| Potential Upside | 14.29 |
Tonix Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tonix Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tonix Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Tonix Pharmaceuticals historical prices to predict the future Tonix Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (1.36) | |||
| Treynor Ratio | (0.05) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tonix Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Tonix Pharmaceuticals Backtested Returns
Tonix Pharmaceuticals appears to be dangerous, given 3 months investment horizon. Tonix Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0713, which indicates the firm had a 0.0713% return per unit of risk over the last 3 months. By inspecting Tonix Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please review Tonix Pharmaceuticals' Variance of 61.72, risk adjusted performance of (0.01), and Coefficient Of Variation of (4,619) to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Tonix Pharmaceuticals holds a performance score of 5. The entity has a beta of 3.42, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Tonix Pharmaceuticals will likely underperform. Please check Tonix Pharmaceuticals' jensen alpha and accumulation distribution , to make a quick decision on whether Tonix Pharmaceuticals' existing price patterns will revert.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Tonix Pharmaceuticals Holding has insignificant reverse predictability. Overlapping area represents the amount of predictability between Tonix Pharmaceuticals time series from 3rd of November 2024 to 18th of November 2024 and 18th of November 2024 to 3rd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tonix Pharmaceuticals price movement. The serial correlation of -0.18 indicates that over 18.0% of current Tonix Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.18 | |
| Spearman Rank Test | -0.15 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Tonix Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Tonix Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Tonix Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Tonix Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Tonix Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Tonix Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Tonix Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Tonix Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Tonix Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Tonix Pharmaceuticals Lagged Returns
When evaluating Tonix Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Tonix Pharmaceuticals stock have on its future price. Tonix Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Tonix Pharmaceuticals autocorrelation shows the relationship between Tonix Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Tonix Pharmaceuticals Holding.
Regressed Prices |
| Timeline |
Pair Trading with Tonix Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tonix Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tonix Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Tonix Stock
The ability to find closely correlated positions to Tonix Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tonix Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tonix Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tonix Pharmaceuticals Holding to buy it.
The correlation of Tonix Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tonix Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tonix Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tonix Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.